Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

Similar articles for PubMed (Select 24306200)

1.

A recurrence-predicting prognostic factor for patients with ovarian clear-cell adenocarcinoma at reproductive age.

Kajiyama H, Mizuno M, Shibata K, Umezu T, Suzuki S, Yamamoto E, Mitsui H, Sekiya R, Niimi K, Kawai M, Nagasaka T, Kikkawa F.

Int J Clin Oncol. 2014 Oct;19(5):921-7. doi: 10.1007/s10147-013-0645-3. Epub 2013 Dec 5.

PMID:
24306200
2.

Survival impact of capsule rupture in stage I clear cell carcinoma of the ovary in comparison with other histological types.

Higashi M, Kajiyama H, Shibata K, Mizuno M, Mizuno K, Hosono S, Kawai M, Nakanishi T, Nagasaka T, Kikkawa F.

Gynecol Oncol. 2011 Dec;123(3):474-8. doi: 10.1016/j.ygyno.2011.08.036. Epub 2011 Sep 28.

PMID:
21955484
3.

Adjuvant chemotherapy for stage i ovarian clear cell carcinoma: is it necessary for stage IA?

Mizuno M, Kajiyama H, Shibata K, Mizuno K, Yamamuro O, Kawai M, Nakanishi T, Nagasaka T, Kikkawa F.

Int J Gynecol Cancer. 2012 Sep;22(7):1143-9. doi: 10.1097/IGC.0b013e31825c7cbe.

PMID:
22801028
4.

Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study.

Chan JK, Tian C, Monk BJ, Herzog T, Kapp DS, Bell J, Young RC; Gynecologic Oncology Group.

Cancer. 2008 May 15;112(10):2202-10. doi: 10.1002/cncr.23390.

5.

Impact of surgical staging in stage I clear cell adenocarcinoma of the ovary.

Suzuki K, Takakura S, Saito M, Morikawa A, Suzuki J, Takahashi K, Nagata C, Yanaihara N, Tanabe H, Okamoto A.

Int J Gynecol Cancer. 2014 Sep;24(7):1181-9. doi: 10.1097/IGC.0000000000000178.

PMID:
25010038
6.

Oncologic outcome after recurrence in patients with stage I epithelial ovarian cancer: are clear-cell and mucinous histological types a different entities?

Kajiyama H, Mizuno M, Shibata K, Umezu T, Suzuki S, Yamamoto E, Mitsui H, Sekiya R, Niimi K, Kawai M, Nagasaka T, Kikkawa F.

Eur J Obstet Gynecol Reprod Biol. 2014 Oct;181:305-10. doi: 10.1016/j.ejogrb.2014.07.046. Epub 2014 Aug 20.

PMID:
25203309
7.

Recurrence-predicting prognostic factors for patients with early-stage epithelial ovarian cancer undergoing fertility-sparing surgery: a multi-institutional study.

Kajiyama H, Mizuno M, Shibata K, Yamamoto E, Kawai M, Nagasaka T, Kikkawa F.

Eur J Obstet Gynecol Reprod Biol. 2014 Apr;175:97-102. doi: 10.1016/j.ejogrb.2014.01.014. Epub 2014 Jan 18.

PMID:
24507757
8.

Impact of guideline adherence on patient outcomes in early-stage epithelial ovarian cancer.

Lee JY, Kim TH, Suh DH, Kim JW, Kim HS, Chung HH, Park NH, Song YS, Kang SB.

Eur J Surg Oncol. 2015 Apr;41(4):585-91. doi: 10.1016/j.ejso.2015.01.006. Epub 2015 Jan 17.

PMID:
25624160
9.

Adjuvant chemotherapy for stage I clear cell carcinoma of the ovary: an analysis of fully staged patients.

Takada T, Iwase H, Iitsuka C, Nomura H, Sakamoto K, Omatsu K, Takeshima N, Takizawa K.

Int J Gynecol Cancer. 2012 May;22(4):573-8. doi: 10.1097/IGC.0b013e31823fd413.

PMID:
22398705
10.
11.

Prognosis of ovarian clear cell carcinoma compared to other histological subtypes: a meta-analysis.

Lee YY, Kim TJ, Kim MJ, Kim HJ, Song T, Kim MK, Choi CH, Lee JW, Bae DS, Kim BG.

Gynecol Oncol. 2011 Sep;122(3):541-7. doi: 10.1016/j.ygyno.2011.05.009. Epub 2011 Jun 2.

PMID:
21640372
12.

Long-term prognosis of stage I ovarian carcinoma. Prognostic importance of intraoperative rupture.

Mizuno M, Kikkawa F, Shibata K, Kajiyama H, Suzuki T, Ino K, Kawai M, Mizutani S.

Oncology. 2003;65(1):29-36.

PMID:
12837980
13.

Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging.

Takano M, Kikuchi Y, Yaegashi N, Kuzuya K, Ueki M, Tsuda H, Suzuki M, Kigawa J, Takeuchi S, Tsuda H, Moriya T, Sugiyama T.

Br J Cancer. 2006 May 22;94(10):1369-74.

14.

Prognostic importance of intraoperative rupture of malignant ovarian epithelial neoplasms.

Sainz de la Cuesta R, Goff BA, Fuller AF Jr, Nikrui N, Eichhorn JH, Rice LW.

Obstet Gynecol. 1994 Jul;84(1):1-7.

PMID:
8008300
15.

The influence of intraoperative tumor rupture on recurrence risk in Stage Ic epithelial ovarian cancer.

Goudge CS, Li Z, Downs LS Jr.

Eur J Gynaecol Oncol. 2009;30(1):25-8.

PMID:
19317252
16.

[Prognostic analysis of 88 patients with ovarian clear cell carcinoma].

Ma SK, Zhang HT, Wu LY, Liu LY.

Zhonghua Zhong Liu Za Zhi. 2007 Oct;29(10):784-8. Chinese.

PMID:
18396695
17.

Comparison of pure and mixed-type clear cell carcinoma of the ovary: a clinicopathological analysis of 341 Chinese patients.

Ye S, You Y, Yang J, Cao D, Bai H, Huang H, Wu M, Chen J, Lang J, Shen K.

Int J Gynecol Cancer. 2014 Nov;24(9):1590-6. doi: 10.1097/IGC.0000000000000275.

PMID:
25254564
18.

Survival impact of initial surgical approach in stage I ovarian cancer.

Wu TI, Lee CL, Liao PJ, Huang KG, Chang TC, Chou HH, Wang CJ, Soong YK, Hsueh S, Lai CH.

Chang Gung Med J. 2010 Sep-Oct;33(5):558-67.

19.

The role of serum CA-125 levels and CA-125 tissue expression positivity in the prediction of the recurrence of stage III and IV epithelial ovarian tumors (CA-125 levels and tissue CA-125 in ovarian tumors).

Gundogdu F, Soylu F, Erkan L, Tatli O, Mavi S, Yavuzcan A.

Arch Gynecol Obstet. 2011 Jun;283(6):1397-402. doi: 10.1007/s00404-010-1589-8. Epub 2010 Jul 20.

PMID:
20645105
20.

Prognostic factors for early-stage epithelial ovarian cancer, treated with adjuvant carboplatin/paclitaxel chemotherapy: a single institution experience.

Bamias A, Karadimou A, Soupos N, Sotiropoulou M, Zagouri F, Haidopoulos D, Thomakos N, Rodolakis A, Antsaklis A, Dimopoulos MA.

Gynecol Oncol. 2011 Oct;123(1):37-42. doi: 10.1016/j.ygyno.2011.06.033. Epub 2011 Jul 18.

PMID:
21764430
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk